ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Changchun GeneScience Pharmaceutical Co., Ltd. clinical trials

Also known as GenSci.

Part of Changchun High-Tech Industries (Group) Co., Ltd., which holds 99.50% as of 2025-12-31. Source

The registry lists 111 studies whose lead sponsor is Changchun GeneScience Pharmaceutical Co., Ltd.. 48 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.

Keep track of what changes. Save the Changchun GeneScience Pharmaceutical Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
32
Recruiting
30
Status unknown
21
Not yet recruiting
18
Active, not recruiting
6
Terminated
3

Phase

Phase 1
52
Phase 2
23
Phase 3
22
Phase 4
10

Where

China
104
United States
1
Australia
1

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Changchun GeneScience Pharmaceutical Co., Ltd..

  • Changchun GeneScience Pharmaceutical Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    111 studies

Focus areas

Conditions Changchun GeneScience Pharmaceutical Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Dwarfism, Pituitary10

Studies

Recruiting first, then most recently updated. Showing 50 of 111. Browse all 111 →